Latest Observability News

Ragnar Metals has confirmed high-grade uranium mineralisation at surface over a 150m strike at its Klockartorpet Project in Sweden, revealing a 1km long uranium anomaly and multiple untested targets. The findings set the stage for further exploration and drilling plans.

NeuroScientific Biopharmaceuticals reports encouraging clinical responses in fistulising Crohn’s disease patients treated under Australia’s Special Access Scheme, setting the stage for pivotal Phase 2 trials later this year.

Amanda Lacaze, the CEO who transformed Lynas Rare Earths from a struggling startup to an ASX50 powerhouse, has announced her retirement. The company is now searching for a new leader to guide its next growth phase.

Perpetual Resources has reported multiple high-grade lithium rock chip assays from its Renaldinho and Morro Grande projects in Brazil, confirming a fertile lithium system and setting the stage for a significant drilling campaign in 2026.

AdAlta Limited has raised A$1.2 million through a strategic placement to advance its innovative PD1 armored MSLN CAR-T therapy for solid cancers, reinforcing its unique 'East to West' cellular immunotherapy approach.

Nova Minerals has reported exceptional 2025 drilling results at its RPM Valley deposit in Alaska, including a record high-grade gold intercept and broad mineralized zones that reinforce the project's potential for significant development.

New Murchison Gold Limited reports significant high-grade gold intercepts from recent drilling at its Lydia Gold Prospect, expanding mineralisation near its flagship Crown Prince Gold Mine. The results pave the way for resource upgrades and potential rapid development leveraging existing infrastructure.

The Takeovers Panel has declined to investigate allegations of undisclosed shareholder associations at Cyclone Metals, following a contentious director removal. This decision signals regulatory confidence in the company’s governance stability.

King River Resources has addressed recent share price and volume spikes, denying undisclosed information and highlighting its significant Tivan Limited holding and ongoing Tennant Creek exploration.

ReNerve Limited has secured broader regulatory approval in Hong Kong for its NervAlign® Nerve Cuff, enabling access to both public and private hospitals and validating the device’s clinical benefits through independent review.

Clinuvel Pharmaceuticals has initiated dosing in a preclinical study of its novel controlled-release injectable peptide platform, VLRX-L, aiming to enhance drug delivery for melanocortin-based therapies. Preliminary results are expected in the second half of 2026.

Haranga Resources has confirmed a significant continuous gold mineralised trend exceeding 800 metres at its Ibel South Gold Project in Senegal, with plans for deeper drilling in early 2026 to explore high-grade zones and untested anomalies.